Oncospark

Ashland, United States
Offers revenue cycle management, prior authorization, and consulting for healthcare organizations.

About Oncospark

Oncospark is a Healthcare company based in Ashland (United States). It offers revenue cycle management, prior authorization, and consulting for healthcare organizations. It operates on a B2B and SaaS model. The company has 553 employees. Its website oncospark.com draws about 681 thousand monthly visits. Its Indian entity Oncospark India Private Limited reported revenue of β‚Ή33.88 Cr. Oncospark offers products and services including Workflow Management, RCM Management, Prior Authorization, and Consulting. Its focus areas include Revenue Cycle Management, Medical Billing, Prior Authorization and Consulting. Its competitors include Performant Financial, Adonis and CorroHealth; 1 of its 3 listed competitors has raised funding.

Company details

OncoSpark assists healthcare providers with revenue cycle management by reducing denied claims and optimizing workflows through software and expert services. They offer prior authorization solutions, consulting for budgets and audits, and benefits management to increase collected revenue. Based in the USA, they partner with physicians and billing companies to navigate reimbursement challenges and improve financial viability with tailored technology and analytics.

  • Headquarters Ashland, United States
  • Employees 553
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website oncospark.com
  • Social LinkedIn X
  • Legal Name Oncospark India Private Limited
  • Date of Incorporation 17 Aug, 2016
  • Jurisdiction Chennai, Tamil Nadu, India
Key Metrics
  • Indian entity revenue
    ₹33.88 Cr

    FY 2025 · +6% YoY

  • Indian entity net profit
    ₹3.31 Cr

    FY 2025 · 10% margin

  • Indian entity EBITDA
    ₹5.78 Cr

    FY 2025 · 17% margin

  • Employee Count
    553

Products & Services of Oncospark

Oncospark offers a comprehensive portfolio of products and services, including Workflow Management, RCM Management, Prior Authorization, and Consulting.

Workflow Management
Software Solution

Optimizes healthcare processes to improve efficiency and reduce errors.

RCM Management
Billing Service

Manages revenue cycles to increase collected revenue for providers.

Prior Authorization
Authorization Tool

Speeds up approvals and decreases denied claims for services.

Consulting
Advisory Service

Guides on budgets, audits, and staffing for healthcare operations.

Board of directors of Oncospark India Private Limited (Oncospark)

Oncospark India Private Limited is the primary company behind Oncospark. The board of Oncospark India Private Limited currently have 4 directors; the longest-serving is Gitika Bafna, appointed in 2016.

DirectorDesignationAppointedTenureEntity
Gitika Bafna
DIN 00375899
Director17 Aug 201610 yrs 2 moOncospark India Private Limited
Gajendra Kumar Surana
DIN 00375833
Director17 Aug 201610 yrs 2 moOncospark India Private Limited
Anupam Jain
DIN 07538437
Director17 Aug 201610 yrs 2 moOncospark India Private Limited
Suganthi Devakumar
DIN 06827180
Director17 Aug 201610 yrs 2 moOncospark India Private Limited

People of Oncospark

10 people are tracked at Oncospark (5 in leadership, 5 in team); the tracked headcount is 553.

NameRoleGroup
Sapan Bafna
Chief Executive OfficerLeadership
Ronald Morton
Chief Revenue OfficerLeadership
Manish Jain
Vice President Of Business DevelopmentLeadership
Nasser Ashour
Vice President Of Client SuccessLeadership
Chandrakant Binwani
Chief AI OfficerLeadership
Emily Johnson
Client Service ManagerTeam
Rajesh R
Senior Client Service ExecutiveTeam
Rajkumar K. Singh
Senior Training ManagerTeam
RUCHI S
Team LeadTeam
Sangeeth K
Senior Executive Human ResourcesTeam
Premium access

Complete people profiles for Oncospark

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Oncospark

Figures of Oncospark India Private Limited, the primary company behind Oncospark, for FY 2025. Revenue was ₹33.88 Cr (+6% year on year). Net profit was ₹3.31 Cr (10% margin). EBITDA was ₹5.78 Cr (17% margin). Revenue has grown at a compounded annual rate of +15% over three years and +15% over five years.

  • ₹33.88 CrRevenue · FY 2025 · +6% YoY
  • ₹3.31 CrNet profit · 10% margin
  • ₹5.78 CrEBITDA · 17% margin
  • ₹50 LakhPaid-up capital
  • 553Employees (provident fund records)
  • +15%Revenue CAGR, 3 years
  • +15%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Oncospark India Private Limited are on its company page.

Premium access

Detailed financial statements for Oncospark

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Oncospark

Oncospark has 3 listed competitors in our database, 1 of them funded. They include Performant Financial, Adonis and CorroHealth.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
performantcorp.com1976Livermore, United States1,023
Recovery solutions for government obligations are provided by Performant Financial.
adonis.io2022Manhattan, United States$53.9M
Adonis is focused on healthcare revenue cycle management software.
corrohealth.com2020Plano, United States8,022
Healthcare revenue cycle management services are delivered to providers.
Premium access

Detailed competitors of Oncospark

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Oncospark

The website of Oncospark (oncospark.com) receives about 680.7K visits a month.

  • Monthly visits
    680.7K

    ▼ 6.7% vs previous month

Similar websites

Websites whose visitors overlap most with Oncospark. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
falconebiz.com
100%
959.8K#63,970View details
tofler.in
97%
556K#105,509View details
zaubacorp.com
96%
4.9M#12,689View details
tracxn.com
92%
2.9M#16,597View details
indiafilings.com
90%
2.1M#29,959View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 40 similar websites and full traffic analytics for Oncospark

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 40 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Hospitals & Clinical Care

3 companies that operate in the same segment as Oncospark (Hospitals & Clinical Care) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Multi-specialty hospitals and surgery centers are operated nationwide.
1968Nashville, Tennessee, United StatesUSD 97.27 MUSD 75.6 B316,000
Standalone veterinary clinics are operated for pet care services.
2017New York, New York, United StatesUSD 98.5 M
Healthcare services, research, education, and community support are provided.
1942United States
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Oncospark

Premium access

Complete news archive for Oncospark

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Oncospark

Oncospark is headquartered in Ashland, United States. It is registered at Ashland, Oregon, United States.

Oncospark has 553 employees.

The primary company behind Oncospark, Oncospark India Private Limited, reported revenue of β‚Ή33.88 Cr for FY 2025, up 6% year on year.

OncoSpark assists healthcare providers with revenue cycle management by reducing denied claims and optimizing workflows through software and expert services. They offer prior authorization solutions, consulting for budgets and audits, and benefits management to increase collected revenue. Based in the USA, they partner with physicians and billing companies to navigate reimbursement challenges and improve financial viability with tailored technology and analytics.

Oncospark's top competitors include Adonis, Performant Financial and CorroHealth.

Oncospark offers Workflow Management, RCM Management, Prior Authorization, and Consulting.

Oncospark operates through Oncospark India Private Limited.

The legal entities of Oncospark currently have 4 directors, including Gitika Bafna, Gajendra Kumar Surana, Anupam Jain and others.

The website of Oncospark receives about 681 thousand visits a month.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available